The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
116106986 11610698 6 F 20150825 20160725 20151008 20160804 EXP GB-TEVA-597211ACC TEVA 77.00 YR M Y 172.00000 KG 20160805 MD GB GB

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
116106986 11610698 1 PS VINCRISTINE VINCRISTINE 1 Intravenous (not otherwise specified) 2 MILLIGRAM DAILY; 10 MG U U UNK 75493 2 MG QD
116106986 11610698 2 SS PREDNISOLONE. PREDNISOLONE 1 Oral 100 MILLIGRAM DAILY; 500 MG U U UNK 89081 100 MG QD
116106986 11610698 3 SS FUROSEMIDE. FUROSEMIDE 1 Oral 40 MILLIGRAM DAILY; Y U UNK 18413 40 MG QD
116106986 11610698 4 SS FUROSEMIDE. FUROSEMIDE 1 Oral Y U UNK 18413 20 MG
116106986 11610698 5 SS OMEPRAZOLE. OMEPRAZOLE 1 Oral 40 MILLIGRAM DAILY; U U UNK 0 40 MG QD
116106986 11610698 6 SS CYCLOPHOSPHAMIDE. CYCLOPHOSPHAMIDE 1 Intravenous (not otherwise specified) 1400 MILLIGRAM DAILY; 7000 MG U U UNK 0 1400 MG QD
116106986 11610698 7 SS INOTUZUMAB OZOGAMICIN INOTUZUMAB OZOGAMICIN 1 Intravenous (not otherwise specified) 1.5 MILLIGRAM DAILY; 6 MG U UNK 0 1.5 MG QD
116106986 11610698 8 SS RITUXIMAB RITUXIMAB 1 Intravenous (not otherwise specified) 720 MILLIGRAM DAILY; 3600 MG U U UNK 0 720 MG QD
116106986 11610698 9 SS MABTHERA RITUXIMAB 1 Intravenous (not otherwise specified) 375 MG/M2 DAILY; Y 1; DAILY DOSE: 375MG/M2 U U 0 375 MG/M**2 SOLUTION FOR INFUSION QD
116106986 11610698 10 SS MABTHERA RITUXIMAB 1 Intravenous (not otherwise specified) 720 MILLIGRAM DAILY; U U 0 720 MG QD
116106986 11610698 11 C ALLOPURINOL. ALLOPURINOL 1 Oral 300 MILLIGRAM DAILY; 3000 MG 0 300 MG QD
116106986 11610698 12 C ASPIRIN. ASPIRIN 1 Oral 75 MILLIGRAM DAILY; 0 75 MG QD
116106986 11610698 13 C CHLORPHENAMINE CHLORPHENIRAMINE MALEATE 1 Intravenous (not otherwise specified) 10 MILLIGRAM DAILY; 50 MG 0 10 MG QD
116106986 11610698 14 C DIGOXIN. DIGOXIN 1 Oral 125 MICROGRAM DAILY; 0 125 UG QD
116106986 11610698 15 C DIGOXIN. DIGOXIN 1 Unknown 0
116106986 11610698 16 C FILGRASTIM FILGRASTIM 1 Subcutaneous 300 MICROGRAM DAILY; 600 UG 0 300 UG QD
116106986 11610698 17 C FLUCONAZOLE. FLUCONAZOLE 1 Oral 50 MILLIGRAM DAILY; 500 MG 0 50 MG QD
116106986 11610698 18 C HYDROXYCHLOROQUINE HYDROXYCHLOROQUINE 1 Oral 400 MILLIGRAM DAILY; 4400 MG 0 200 MG BID
116106986 11610698 19 C LEFLUNOMIDE. LEFLUNOMIDE 1 Oral 20 MILLIGRAM DAILY; 0 20 MG QD
116106986 11610698 20 C METOCLOPRAMIDE. METOCLOPRAMIDE 1 Oral DOSE: 10-20 MG 0
116106986 11610698 21 C ONDANSETRON ONDANSETRON 1 Oral 8 MILLIGRAM DAILY; 40 MG 0 8 MG QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
116106986 11610698 1 Diffuse large B-cell lymphoma
116106986 11610698 2 Diffuse large B-cell lymphoma
116106986 11610698 3 Cardiac disorder
116106986 11610698 5 Gastrointestinal haemorrhage
116106986 11610698 6 Diffuse large B-cell lymphoma
116106986 11610698 7 Diffuse large B-cell lymphoma
116106986 11610698 8 Diffuse large B-cell lymphoma
116106986 11610698 9 Diffuse large B-cell lymphoma
116106986 11610698 11 Prophylaxis
116106986 11610698 12 Aortic valve replacement
116106986 11610698 13 Unevaluable event
116106986 11610698 14 Atrial fibrillation
116106986 11610698 16 White blood cell count
116106986 11610698 17 Antifungal prophylaxis
116106986 11610698 18 Rheumatoid arthritis
116106986 11610698 19 Rheumatoid arthritis
116106986 11610698 20 Vomiting
116106986 11610698 21 Vomiting

Outcome of event

Event ID CASEID OUTC COD
116106986 11610698 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
116106986 11610698 Blood lactic acid increased
116106986 11610698 Hyponatraemia
116106986 11610698 Lower respiratory tract infection

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
116106986 11610698 1 20150820 20150820 0
116106986 11610698 2 20150820 20150824 0
116106986 11610698 3 20150826 0
116106986 11610698 5 20150826 0
116106986 11610698 6 20150820 20150820 0
116106986 11610698 7 20150821 20150821 0
116106986 11610698 8 20150820 20150820 0
116106986 11610698 9 20150820 20150820 0
116106986 11610698 10 20150820 20150820 0
116106986 11610698 11 20150815 20150826 0
116106986 11610698 12 20150826 0
116106986 11610698 13 20150820 20150820 0
116106986 11610698 14 20150826 0
116106986 11610698 15 20150815 20150826 0
116106986 11610698 16 20150823 20150826 0
116106986 11610698 17 20150815 20150826 0
116106986 11610698 18 20150814 20150826 0
116106986 11610698 19 201107 20150826 0
116106986 11610698 20 20150820 20150826 0
116106986 11610698 21 20150820 20150820 0